Kingston General Hospital
Kingston, Ontario, K7L 2V7, Canada
NCT Number: NCT00537472
This study plans to investigate whether a reduced dose of bupivacaine (a local anesthetic numbing drug) injected into the spinal space for a total knee replacement will result in a shorter time to discharge from the recovery room while maintaining adequate surgical anesthesia.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Kingston, Ontario, K7L 2V7, Canada
With the doses of bupivacaine currently being used in spinal anesthetics at our institution, patients' sensory blocks are often much higher than needed to achieve adequate surgical anesthesia. This translates into a prolonged waiting period in the recovery room before the level regresses down to the pre-existing standard for discharge to the ward, as well as the pre-existing level before a post-operative nerve block for extended pain relief can be performed. This prolonged period in the recovery room leads to general delays in operating room usage and thus surgical cancellations. The excessive drug doses currently used also put patients at risk for increasing side effects including low blood pressure, slow heart rates, and nausea and vomiting.
By using a reduced dose of bupivacaine in a spinal anesthetic for a one sided knee replacement, we hope to significantly reduce the recovery room waiting times until the criteria for recovery room discharge or completion of a post-operative nerve block are met, while still providing adequate surgical anesthesia.
Patients will receive either 9 mg (intervention dose) or 13 mg (control dose) of bupivacaine through a spinal injection. Once the patients enter the recovery room after surgery the level of their sensory block will be tested as per usual protocol by the recovery room nurses every 15 minutes until a predefined level has been reached, and the two groups will be compared.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bupivacaine 9 mg intrathecal single shot injection at start of surgery
Bupivacaine 13 mg intrathecal single shot injection at start of surgery
Time frame: Until recovery room discharge post surgery
Time frame: Until end of surgery
Time frame: Until recovery room discharge criteria are met
Time frame: Until criteria are met for post operative nerve block in recovery room
Queen's University
Other
Low Dose Spinal Bupivacaine for Total Knee Arthroplasty and Recovery Room Wait Time
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07112313
Spinal Anesthesia, Total Knee Arthroplasty
Elâzığ, Merkez, Turkey (Türkiye)
View Trial DetailsNCT04485650
Anxiety, Anxiety Disorders
Bolu, Turkey (Türkiye)
View Trial DetailsNCT07718360
Cesarean Section Pain, Neurologic Manifestations
Islamabad, Federal Capital Territory, Pakistan
View Trial DetailsNCT06711601
Intercristal Line, Posterior Superior Iliac Spine
Guangzhou, Guangdong, China
View Trial Details